Clinical signs of androgen excess as risk factors for coronary artery disease
Authors:
- Blair GrubbBGBlair Grubb
- Arthur HartzAHArthur Hartz
- Joseph J. Van NortJNJoseph J. Van Nort
- William BachmanWBWilliam Bachman
- Mary BartholomewMBMary Bartholomew
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 54 (2) , 255-259
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndromeAmerican Journal of Obstetrics and Gynecology, 1988
- Lipoprotein Lipid Concentrations and Cardiovascular Risk in Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 1985
- Cardiovascular Imaging: Coronary Artery StenosisHospital Practice, 1984
- Quantitative coronary angiography: measurement of the "critical" stenosis in patients with unstable angina and single-vessel disease without collaterals.Circulation, 1979
- 3α-Androstanediol Kinetics in ManJournal of Clinical Investigation, 1974
- Effects of coronary stenoses on coronary flow reserve and resistanceThe American Journal of Cardiology, 1974
- Physiologic basis for assessing critical coronary stenosisThe American Journal of Cardiology, 1974
- Simultaneous Determination of Urinary Androstanediol and Testosterone as an Evaluation of Human AndrogenicityThe Journal of Clinical Endocrinology & Metabolism, 1973
- The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5α-androstanediolsJournal of Clinical Investigation, 1971
- The Polycystic Ovary. I. Clinical and Histologic FeaturesThe Journal of Clinical Endocrinology & Metabolism, 1962